Showing results (341-350 of 588) with videos related to

Sort By:
Pageof 59
Cancer Immunology Research|May 28, 2015
Differential Expression of PD-L1 between Primary and Metastatic Sites in Clear-Cell Renal Cell CarcinomaMarcella Callea, Laurence Albiges, Mamta Gupta, et al.
Cancer Cell|June 15, 2007
Identification of the JNK signaling pathway as a functional target of the tumor suppressor PTENIgor Vivanco, Nicolaos Palaskas, Chris Tran, et al.
BJU International|August 26, 2010
Novel ZEB1 expression in bladder tumorigenesisPatrick A Kenney, Matthew F Wszolek, Kimberly M Rieger-Christ, et al.
Molecular Cancer Research : MCR|July 1, 2015
Measuring PI3K Activation: Clinicopathologic, Immunohistochemical, and RNA Expression Analysis in Prostate CancerNeil E Martin, Travis Gerke, Jennifer A Sinnott, et al.
Carcinogenesis|April 15, 2015
Molecular differences in transition zone and peripheral zone prostate tumorsJennifer A Sinnott, Jennifer R Rider, Jessica Carlsson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2005
Molecular alterations in tumors and response to combination chemotherapy with gefitinib for advanced colorectal cancerShuji Ogino, Jeffrey A Meyerhardt, Mami Cantor, et al.
The Lancet. Oncology|December 11, 2012
Single nucleotide polymorphisms and risk of recurrence of renal-cell carcinoma: a cohort studyFabio A B Schutz, Mark M Pomerantz, Kathryn P Gray, et al.
BMC Medical Research Methodology|December 24, 2014
Genomic investigation of etiologic heterogeneity: methodologic challengesColin B Begg, Venkatraman E Seshan, Emily C Zabor, et al.
Nature Communications|January 9, 2020
BCL9 provides multi-cellular communication properties in colorectal cancer by interacting with paraspeckle proteinsMeng Jiang, Yue Kang, Tomasz Sewastianik, et al.
Molecular Therapy Oncolytics|February 4, 2022
Anti-CAIX BBζ CAR4/8 T cells exhibit superior efficacy in a ccRCC mouse modelYufei Wang, Alicia Buck, Marion Grimaud, et al.
Pageof 59